chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Injection site pain, Muscle spasms, Myalgia
Clinical narrative: Myalgia, Arthralgia,  Injection site soreness and hands cramping Narrative:
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia
Clinical narrative: Headache, Myalgia, Chills Narrative:
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: Headache, Myalgia & Fever Narrative:
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Headache, Influenza like illness
Clinical narrative: Headache, Arthralgia, Diarrhea, Chills, Flu-like Symptoms Narrative:  No further details given
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Pyrexia
Clinical narrative: Headache, Arthralgia, Fever,  Fatigue Narrative: Fever 100.9, took Tylenol
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia
Clinical narrative: Headache, Myalgia, Fatigue, Chills Narrative:
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Myalgia
Clinical narrative: Myalgia, Arthralgia,  Fatigue Narrative: Took Tylenol
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Headache & Fever Narrative: Took Ibuprofen
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Arthralgia Narrative:
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea, Vomiting
Clinical narrative: Headache & NauseaVomiting Narrative: Took Tylenol
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Injection site pain, Pyrexia
Clinical narrative: Headache, Fever, Chills, Injection site soreness Narrative:
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Narrative: Headache, Myalgia, Arthralgia, Fever, Fatigue, Chills.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Narrative: Headache, Myalgia, Arthralgia, Fever, Fatigue, Chills.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Nausea, Restless legs syndrome
Clinical narrative: Arthralgia, NauseaVomiting, chills, fatigue, restless muscles Narrative:
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Arthralgia, NauseaVomiting, chills, fatigue, restless muscles Narrative:
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Blindness, Chest pain, Eye pain, Eyeglasses therapy
Clinical narrative: Blurred Vision Blurred vision, sharp eye pain, eye pressure, abdominal pain, chest pain, loss of vision, light sensitivity, fatugue Narrative:  Patient reports continued loss of vision/severe blurred vision and light sensitivity. Patient never required glasses/any vision correction previously and now requires prescription glasses and adjustment for light sensitivity
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Ocular discomfort, Photophobia, Vision blurred
Clinical narrative: Blurred Vision Blurred vision, sharp eye pain, eye pressure, abdominal pain, chest pain, loss of vision, light sensitivity, fatugue Narrative:  Patient reports continued loss of vision/severe blurred vision and light sensitivity. Patient never required glasses/any vision correction previously and now requires prescription glasses and adjustment for light sensitivity
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Grip strength decreased, Middle insomnia, Muscular weakness, Pain in extremity
Clinical narrative: pain Narrative: pain, weakness right arm, soreness. wakes  up at night and unable to grasp w/hand
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia
Clinical narrative: Narrative: Myalgia, Fatigue.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Vomiting
Clinical narrative: Narrative: Myalgia & Nausea Vomiting
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Chills, Fatigue, Headache, Injection site pain
Clinical narrative: Headache, Myalgia, Fever, NauseaVomiting,  injection site pain radiating to the hand with burning sensation. fever, chills, nauseated, fatigue, body aches Narrative:
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pain, Pain in extremity, Pyrexia
Clinical narrative: Headache, Myalgia, Fever, NauseaVomiting,  injection site pain radiating to the hand with burning sensation. fever, chills, nauseated, fatigue, body aches Narrative:
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Headache, Myalgia, Fever, NauseaVomiting,  injection site pain radiating to the hand with burning sensation. fever, chills, nauseated, fatigue, body aches Narrative:
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Injection site pain
Clinical narrative: injection site pain, weakness Narrative:
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Oropharyngeal pain, Pain
Clinical narrative: Myalgia Narrative: Reports body aches all over his  body since getting the vaccine. Also experiencing occasional sore throat.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dysphonia, Pain, Productive cough, Sputum discoloured
Clinical narrative: cough up green colored mucus maybe once/twice a day. Raspy Voice at times ,body aches chills Narrative:
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: Headache & Myalgia Narrative:
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Myalgia, Pain in extremity
Clinical narrative: Narrative: Myalgia, Diarrhea, arm pain.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Myalgia, Pyrexia
Clinical narrative: Myalgia, Arthralgia, Fever Chills Narrative: Fever 101
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Headache, Myalgia, Arthralgia, NauseaVomiting, Fatigue Narrative:
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Headache, Myalgia, Arthralgia, NauseaVomiting, Fatigue Narrative:
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Influenza like illness, Pyrexia
Clinical narrative: Headache, Arthralgia, Fever, Flu-like Symptoms Narrative: Fever 101
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Myalgia
Clinical narrative: Headache, Myalgia, Arthralgia, Chills Narrative:
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia
Clinical narrative: Myalgia Fatigue Narrative:
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Narrative: Fever 99 evening of injection, subsided by morning.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Nausea
Clinical narrative: Headache, Arthralgia, NauseaVomiting, Fatigue, Chills Narrative:
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Headache, Arthralgia, NauseaVomiting, Fatigue, Chills Narrative:
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Pyrexia
Clinical narrative: Arthralgia, Fever, Fatigue Narrative:  Fever 99
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Headache, Malaise, Pain in extremity
Clinical narrative: Headache CHEST PAIN, ARM SORNESS Narrative:  STATES DID NOT FEEL WELL X 2 DAYS
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Myalgia, Pruritus, Pyrexia
Clinical narrative: Myalgia, Fever, Sore at injection site and itchy Narrative:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Pain in extremity, Vomiting
Clinical narrative: NauseaVomiting fatigue, arm pain Narrative:
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: arm pain/swelling/redness as injection site Narrative:
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: Headache & Myalgia Narrative:  No further details given
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Pain
Clinical narrative: Headache & Arthralgia Narrative:  Headache and body aches day after injection. Took Tylenol and Ibuprofen.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Nausea, Pyrexia, Vomiting
Clinical narrative: Myalgia, Arthralgia, Fever & NauseaVomiting Narrative:  No additional details provided
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia
Clinical narrative: Headache, Myalgia, fever, chills Narrative:
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Injection site swelling, Pyrexia
Clinical narrative: Fever, Rash, swollen injection site Narrative:
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain lower
Clinical narrative: RLQ abdominal pain Narrative:
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Nausea, Pyrexia, Vomiting
Clinical narrative: Fever, NauseaVomiting, chills Narrative:
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Confusional state, Dizziness, Fatigue, Headache
Clinical narrative: Headache, Myalgia, Fever, chills, light headed, fatigue, confusion Narrative:
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Headache, Myalgia, Fever, chills, light headed, fatigue, confusion Narrative:
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: Tachycardia Narrative:  Employee went home for mild tachycardia (100bpm) at the time of this report.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Injection site pain, Pain in extremity
Clinical narrative: Injection site soreness, right arm pain, fatigue, chills Narrative:
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Injection site pain and soft lump Narrative:
Age: 1.17
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache
Clinical narrative: Dizziness, Headache, Fatigue Narrative:
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Fatigue
Clinical narrative: Arthralgia, Diarrhea, Fatigue Narrative:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Rash, Vomiting
Clinical narrative: Rash & NauseaVomiting Narrative:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nausea, Vomiting
Clinical narrative: Headache, Myalgia & NauseaVomiting Narrative:
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Pruritus, Rash, Urticaria
Clinical narrative: UrticariaPruritus developed shingles Narrative:  Patient began feeling itchy on Sunday, 11/14/21 and rash started Monday, 11/15/21. Determined to be shingles
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Myalgia
Clinical narrative: Headache, Sedation, Myalgia, Arthralgia, none Narrative:
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Headache INJECTION SITE SORENESS AND ITCHING, SWELLING, FATIGUE, NIGHT SWEATS, PAIN ON SIDE OF BODY VACCINATED Narrative:
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Night sweats, Pain
Clinical narrative: Headache INJECTION SITE SORENESS AND ITCHING, SWELLING, FATIGUE, NIGHT SWEATS, PAIN ON SIDE OF BODY VACCINATED Narrative:
Age: 1.5
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache
Clinical narrative: Headache, Arthralgia, chills Narrative:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Hyperhidrosis, Nausea, Vomiting
Clinical narrative: Headache, NauseaVomiting, CHILLS, SWEATS Narrative:  HEADACHE X 48 HOURS
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Lymphadenopathy, Malaise, Myalgia
Clinical narrative: Myalgia, Arthralgia, Malaise, lymphadenopathy Left axilla Narrative:
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia, Tachycardia
Clinical narrative: Headache, Fever & Tachycardia Narrative:
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Myalgia
Clinical narrative: Myalgia, Arthralgia, Chills Narrative:  No further details
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Injection site bruising, Injection site erythema, Injection site joint pain, Injection site nodule
Clinical narrative: INJECTION SITE: REDNESS, BRUISING, PAIN, KNOT Narrative: EMPLOYEES STATES DEVELOPED JOINT PAIN IN ARM AND HAND OF INJECTION AND NEXT DAY PAIN IN UNDERARM AND SWOLLEN UNDERARM LYMPH NODES ON INJECTION SIDE.
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Lymphadenopathy
Clinical narrative: INJECTION SITE: REDNESS, BRUISING, PAIN, KNOT Narrative: EMPLOYEES STATES DEVELOPED JOINT PAIN IN ARM AND HAND OF INJECTION AND NEXT DAY PAIN IN UNDERARM AND SWOLLEN UNDERARM LYMPH NODES ON INJECTION SIDE.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dyskinesia, Erythema multiforme, Feeling abnormal, Headache
Clinical narrative: Headache, SkinRash, ErythemaMultiform, NauseaVomiting, weakness, brain fog, jerking/shaking Narrative:
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Rash, Tremor, Vomiting
Clinical narrative: Headache, SkinRash, ErythemaMultiform, NauseaVomiting, weakness, brain fog, jerking/shaking Narrative:
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Headache, Malaise, Nausea, Vomiting
Clinical narrative: Headache, NauseaVomiting, malaise armpit pain Narrative:
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Pruritus, Urticaria
Clinical narrative: UrticariaPruritus DIAPHORESIS Narrative:  PT SEEN BY EMPLOYEE HEALTH ARNP. V/S STABLE. SHE HAS NEVER HAD A VACCINE BUT HAD TO TAKE A MANDATORY COVID. ITCHING WITH IN 15MINUTES. SHE TOO BENADRYL 25MG PO OF HER OWN MEDS AND REACTION RESOLVED.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Myalgia
Clinical narrative: Myalgia Brain fog Narrative:
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Dyskinesia, Feeling cold, Feeling hot, Mobility decreased
Clinical narrative: Feeling cold, involuntary muscle jerking, unable to move; feeling warm from head to toe Narrative:
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache
Clinical narrative: Headache fatigue, chills Narrative:
Age: 1.08
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache
Clinical narrative: Dizziness & Headache Narrative:
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: Alert/Responsive. Medical Assistant  Administered peds Dose 0.2 instead  of adult Dose 0.3. No Adverse Reactions Noted. DOM & Family Notified
Age: 48.0
Sex: M
Vaccine: COVID19, HEP
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient was giving a .25mg does of Moderna,  after it was brought to my attention that the vaccine was past the time (expired).  No known reaction.
Age: 14.0
Sex: F
Vaccine: HPV9
Symptoms: Asthenia, Pain in extremity, Paraesthesia, Skin discolouration
Clinical narrative: States within 1-2 hrs (L) arm painful, tingling, hand discolored, (L) side body felt weak over course of few days until seen, symptoms improved but not resolved
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine given after it had expired.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine given after it had expired
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was giving a Moderna .25 (booster dose) Later it was discovered that the vial was expired, due to time out.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Death, Intensive care, Pneumonia, SARS-CoV-2 test negative
Clinical narrative: Narrative:  66yo female died inpatient at hospital MICU on 12/23/2021. Death was caused by: Pneumonia, Acute hypoxic respiratory failure, septic shock (COVID NEGATIVE). Patient was terminally extubated per family's wishes..Pt had received covid vaccines on 3/15/21, 4/12/21, & 11/8/21. Death is not related to covid vaccines.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Septic shock
Clinical narrative: Narrative:  66yo female died inpatient at hospital MICU on 12/23/2021. Death was caused by: Pneumonia, Acute hypoxic respiratory failure, septic shock (COVID NEGATIVE). Patient was terminally extubated per family's wishes..Pt had received covid vaccines on 3/15/21, 4/12/21, & 11/8/21. Death is not related to covid vaccines.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abnormal behaviour, COVID-19, Carotid arteriosclerosis, Cerebral atrophy, Computerised tomogram head abnormal
Clinical narrative: Narrative: Admitted: JAN 3,2022 Discharged: JAN 5,2022 71yoM with PMHx HPL, T2DM, CVA (with residual UE paralysis) who presented to Emergency Room 1/3/22 from home. The patient is vaccinated x2 against COVID- 19 and had a sick contact (wife, +COVID) at home. Per wife, his behavior was altered from norm, including increased drowsiness, decreased appetite and confusion. The patient reportedly had onset of cough and upper respiratory symptoms on Friday 12/31/21, which continued to worsen. On Monday morning 1/3/22 patient was very difficult to arouse and very lethargic, which is off his baseline. Patient was admitted with COVID infection which may likely be contributing to encephalopathy, however ruled out superimposed infection, structural causes, electrolyte imbalances. Not candidate or dex/remdesivir given no O2 requirement. This improved by discahrge. At discharge, he was oriented x 3 and mentating appropriately, following commands, and was at baseline. He was not hypoxic on day of discharge. O2 sat was checked and was 98% at rest. Given that he was not hypoxic and his encephalopathy improved, he was deemed stable for discharge.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Confusional state, Cough, Depressed level of consciousness, Encephalopathy, Exposure to SARS-CoV-2
Clinical narrative: Narrative: Admitted: JAN 3,2022 Discharged: JAN 5,2022 71yoM with PMHx HPL, T2DM, CVA (with residual UE paralysis) who presented to Emergency Room 1/3/22 from home. The patient is vaccinated x2 against COVID- 19 and had a sick contact (wife, +COVID) at home. Per wife, his behavior was altered from norm, including increased drowsiness, decreased appetite and confusion. The patient reportedly had onset of cough and upper respiratory symptoms on Friday 12/31/21, which continued to worsen. On Monday morning 1/3/22 patient was very difficult to arouse and very lethargic, which is off his baseline. Patient was admitted with COVID infection which may likely be contributing to encephalopathy, however ruled out superimposed infection, structural causes, electrolyte imbalances. Not candidate or dex/remdesivir given no O2 requirement. This improved by discahrge. At discharge, he was oriented x 3 and mentating appropriately, following commands, and was at baseline. He was not hypoxic on day of discharge. O2 sat was checked and was 98% at rest. Given that he was not hypoxic and his encephalopathy improved, he was deemed stable for discharge.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lethargy, Respiratory symptom, SARS-CoV-2 test positive, Somnolence
Clinical narrative: Narrative: Admitted: JAN 3,2022 Discharged: JAN 5,2022 71yoM with PMHx HPL, T2DM, CVA (with residual UE paralysis) who presented to Emergency Room 1/3/22 from home. The patient is vaccinated x2 against COVID- 19 and had a sick contact (wife, +COVID) at home. Per wife, his behavior was altered from norm, including increased drowsiness, decreased appetite and confusion. The patient reportedly had onset of cough and upper respiratory symptoms on Friday 12/31/21, which continued to worsen. On Monday morning 1/3/22 patient was very difficult to arouse and very lethargic, which is off his baseline. Patient was admitted with COVID infection which may likely be contributing to encephalopathy, however ruled out superimposed infection, structural causes, electrolyte imbalances. Not candidate or dex/remdesivir given no O2 requirement. This improved by discahrge. At discharge, he was oriented x 3 and mentating appropriately, following commands, and was at baseline. He was not hypoxic on day of discharge. O2 sat was checked and was 98% at rest. Given that he was not hypoxic and his encephalopathy improved, he was deemed stable for discharge.
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain, Acquired diaphragmatic eventration, Acute respiratory failure, Aortic dilatation, Atrial fibrillation
Clinical narrative: ADMITTED: JAN 3,2022 DISCHARGED: JAN 8,2022 DISCHARGE DIAGNOSIS: Acute Hypoxic Respiratory Failure due to Covid Pneumonia 90 yo Male w/ significant vascular history {CABG 1990's, EVAR 2020, bilateral LE amputations}, HTN, HLD here w/ abdominal pain found to be positive for COVID19 {fully vaccinated, boosted}. He was initially stable on room air without conversational dyspnea and was admitted for closer monitoring given his age and solitary living situation. However, within few hours of being on the floor, he had rapid escalation in O2 requirement {up to 12L oxymizer} and new tachycardia to 120 w/ AF RVR. He was transferred to the ICU for further care. Pt was quickly weaned to 10L oxymizer. Pt initially in A-fib w/ RVR during hypoxic episode, though became rate-controlled without intervention in the ICU. Acute Hypoxic Respiratory Failure in setting of COVID10, w/ concern for superimposed Pneumonia. Patient received remdesivir and prednisone and enoxaparin as described. Discharged to home when stable.
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Chronic obstructive pulmonary disease, Hypoxia
Clinical narrative: ADMITTED: JAN 3,2022 DISCHARGED: JAN 8,2022 DISCHARGE DIAGNOSIS: Acute Hypoxic Respiratory Failure due to Covid Pneumonia 90 yo Male w/ significant vascular history {CABG 1990's, EVAR 2020, bilateral LE amputations}, HTN, HLD here w/ abdominal pain found to be positive for COVID19 {fully vaccinated, boosted}. He was initially stable on room air without conversational dyspnea and was admitted for closer monitoring given his age and solitary living situation. However, within few hours of being on the floor, he had rapid escalation in O2 requirement {up to 12L oxymizer} and new tachycardia to 120 w/ AF RVR. He was transferred to the ICU for further care. Pt was quickly weaned to 10L oxymizer. Pt initially in A-fib w/ RVR during hypoxic episode, though became rate-controlled without intervention in the ICU. Acute Hypoxic Respiratory Failure in setting of COVID10, w/ concern for superimposed Pneumonia. Patient received remdesivir and prednisone and enoxaparin as described. Discharged to home when stable.
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Intensive care, Lung infiltration, Pneumonia, Pulmonary fibrosis, SARS-CoV-2 test positive
Clinical narrative: ADMITTED: JAN 3,2022 DISCHARGED: JAN 8,2022 DISCHARGE DIAGNOSIS: Acute Hypoxic Respiratory Failure due to Covid Pneumonia 90 yo Male w/ significant vascular history {CABG 1990's, EVAR 2020, bilateral LE amputations}, HTN, HLD here w/ abdominal pain found to be positive for COVID19 {fully vaccinated, boosted}. He was initially stable on room air without conversational dyspnea and was admitted for closer monitoring given his age and solitary living situation. However, within few hours of being on the floor, he had rapid escalation in O2 requirement {up to 12L oxymizer} and new tachycardia to 120 w/ AF RVR. He was transferred to the ICU for further care. Pt was quickly weaned to 10L oxymizer. Pt initially in A-fib w/ RVR during hypoxic episode, though became rate-controlled without intervention in the ICU. Acute Hypoxic Respiratory Failure in setting of COVID10, w/ concern for superimposed Pneumonia. Patient received remdesivir and prednisone and enoxaparin as described. Discharged to home when stable.
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Superinfection, Tachycardia
Clinical narrative: ADMITTED: JAN 3,2022 DISCHARGED: JAN 8,2022 DISCHARGE DIAGNOSIS: Acute Hypoxic Respiratory Failure due to Covid Pneumonia 90 yo Male w/ significant vascular history {CABG 1990's, EVAR 2020, bilateral LE amputations}, HTN, HLD here w/ abdominal pain found to be positive for COVID19 {fully vaccinated, boosted}. He was initially stable on room air without conversational dyspnea and was admitted for closer monitoring given his age and solitary living situation. However, within few hours of being on the floor, he had rapid escalation in O2 requirement {up to 12L oxymizer} and new tachycardia to 120 w/ AF RVR. He was transferred to the ICU for further care. Pt was quickly weaned to 10L oxymizer. Pt initially in A-fib w/ RVR during hypoxic episode, though became rate-controlled without intervention in the ICU. Acute Hypoxic Respiratory Failure in setting of COVID10, w/ concern for superimposed Pneumonia. Patient received remdesivir and prednisone and enoxaparin as described. Discharged to home when stable.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Conversion disorder, Dyskinesia
Clinical narrative: Narrative:  functional neurological disorders (once called psychogenic) have been reported following COVID vaccination
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Ascites, Death, Hepatic cirrhosis, Portal hypertension, Splenomegaly
Clinical narrative: Narrative:  75yo male patient with cirrhosis with portal hypertension, ascites and splenomegaly died outside of facility, place & circumstances not mentioned in system. Pt had received covid vaccines on 3/29/21 & 4/26/21. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: CHEST PAIN/CRAMPING IN AND AROUND HEART; This spontaneous report received from a patient concerned a 38 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802070, and expiry: 23-AUG-2021) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-MAR-2021, the patient experienced chest pain/cramping in and around heart. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chest pain/cramping in and around heart on 13-MAR-2021. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Dry mouth, Pain in extremity
Clinical narrative: arm pain radiated to her armpit; dry mouth; This is a spontaneous report received from contactable reporter(s) (Pharmacist) from medical information team. The reporter is the patient.  A 39 year-old female patient received bnt162b2 (BNT162B2), administration date 26Feb2021 (Lot number: EN6203, Expiration Date: Jun2021) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "arm pain radiated to her armpit"; DRY MOUTH (non-serious) with onset 2021, outcome "unknown", described as "dry mouth".  Additional information: Caller stated she received the first dose of the Pfizer covid vaccine on the 26Feb and she is still having arm pain radiated to her armpit, no rash, she says it feels swelling but her doctor did not see any swelling at the site. Caller wanted to know about the prolonged site pain, dry mouth and can the vaccine throw off the menstrual cycle. Caller is 39 years old female.  No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fatigue, Lethargy, Nausea
Clinical narrative: Fatigue; lightheadedness; slight nausea; tingling in left arm and lips; weakness; Lethargy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 66 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 03Mar2021 10:15 (Lot number: EL9261) at the age of 66 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious) with onset 05Mar2021, outcome "not recovered", described as "lightheadedness"; NAUSEA (non-serious) with onset 05Mar2021, outcome "not recovered", described as "slight nausea"; PARAESTHESIA (non-serious) with onset 05Mar2021, outcome "not recovered", described as "tingling in left arm and lips"; ASTHENIA (non-serious) with onset 05Mar2021, outcome "not recovered", described as "weakness"; LETHARGY (non-serious) with onset 05Mar2021, outcome "not recovered", described as "Lethargy"; FATIGUE (non-serious), outcome "unknown", described as "Fatigue". Therapeutic measures were not taken as a result of dizziness, nausea, paraesthesia, asthenia, lethargy. Additional information: Patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.The patient did not receive any other vaccines within four weeks prior to the vaccination No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Fatigue; lightheadedness; slight nausea; tingling in left arm and lips; weakness; Lethargy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 66 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 03Mar2021 10:15 (Lot number: EL9261) at the age of 66 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious) with onset 05Mar2021, outcome "not recovered", described as "lightheadedness"; NAUSEA (non-serious) with onset 05Mar2021, outcome "not recovered", described as "slight nausea"; PARAESTHESIA (non-serious) with onset 05Mar2021, outcome "not recovered", described as "tingling in left arm and lips"; ASTHENIA (non-serious) with onset 05Mar2021, outcome "not recovered", described as "weakness"; LETHARGY (non-serious) with onset 05Mar2021, outcome "not recovered", described as "Lethargy"; FATIGUE (non-serious), outcome "unknown", described as "Fatigue". Therapeutic measures were not taken as a result of dizziness, nausea, paraesthesia, asthenia, lethargy. Additional information: Patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.The patient did not receive any other vaccines within four weeks prior to the vaccination No follow-up attempts are possible. No further information is expected.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Arteriosclerosis, COVID-19, Cardiac failure congestive, Death, SARS-CoV-2 test positive
Clinical narrative: pt recently hospitalized for 1 week with CHF and positive for COVID; dc'd to hospice facility; pt passed away in the facility due to COVID, CHF, atherosclerotic cardiovascular disease
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Genital ulceration, Vaginal disorder, Vulvovaginal erythema, Vulvovaginal pain
Clinical narrative: genital ulcers; Very painful; reddened sores in the vaginal area; reddened sores in the vaginal area; reddened sores in the vaginal area; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 15 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 10Jun2021 (Lot number: E100187) at the age of 15 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Covid" (unspecified if ongoing), notes: If covid prior vaccination: Yes. Concomitant medication(s) included: TRI-SPRINTEC. Vaccination history included: Bnt162b2 (Product: COVID 19, brand: Pfizer, lot number: GCV0185, lot unknown: False, administration: date: 20May2021 , dose number: 1, vaccine location: Left arm), administration date: 20May2021, when the patient was 15 years old, for COVID-19 immunisation. The following information was reported: GENITAL ULCERATION (non-serious) with onset 13Jun2021, outcome "recovered", described as "genital ulcers"; VULVOVAGINAL PAIN (non-serious) with onset 13Jun2021, outcome "recovered", described as "Very painful"; VULVOVAGINAL ERYTHEMA (non-serious), VULVOVAGINAL DISCOMFORT (non-serious), VAGINAL DISORDER (non-serious) all with onset 13Jun2021, outcome "recovered" and all described as "reddened sores in the vaginal area". The events "genital ulcers", "very painful", "reddened sores in the vaginal area", "reddened sores in the vaginal area" and "reddened sores in the vaginal area" were evaluated at the physician office visit. Therapeutic measures were taken as a result of genital ulceration, vulvovaginal pain, vulvovaginal erythema, vulvovaginal discomfort, vaginal disorder.  Additional information: Approximately 48-72 hours after the 2nd vaccine dose, genital ulcers were present. Very painful, reddened sores in the vaginal area. Lidocaine ointment, cortisone cream, oral pain meds were considered as treatment drug for all events.Patient was not tested covid post vaccination and no known allergies.   No follow-up attempts are possible. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anti-cyclic citrullinated peptide antibody, Anti-thyroid antibody, Antinuclear antibody negative, Asthenia, Blood folate normal
Clinical narrative: followed by 10 days of arm and hand tremors in both arms; muscle weakness; possible vaccine induced neuro inflammation; Piercing headache on Day 1; sensation of entire torso vibrating; joint pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 08Aug2021 11:00 (Lot number: FC3180) at the age of 41 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Allergy to pollen" (unspecified if ongoing), notes: Tree pollen; "Allergy to cat dander" (unspecified if ongoing), notes: Cat dander. Concomitant medication(s) included: VITAMINE D; MULTIVIT [VITAMINS NOS]; PROBIOTICS; TURMERIC CURCUMIN. The following information was reported: TREMOR (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "followed by 10 days of arm and hand tremors in both arms"; MUSCULAR WEAKNESS (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "muscle weakness"; INFLAMMATION (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "possible vaccine induced neuro inflammation"; HEADACHE (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "Piercing headache on Day 1"; FEELING ABNORMAL (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "sensation of entire torso vibrating"; ARTHRALGIA (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "joint pain". The events "followed by 10 days of arm and hand tremors in both arms", "muscle weakness", "possible vaccine induced neuro inflammation", "piercing headache on day 1", "sensation of entire torso vibrating" and "joint pain" were evaluated at the physician office visit and emergency room visit. Therapeutic measures were taken as a result of tremor, muscular weakness, inflammation, headache, feeling abnormal, arthralgia.  Additional information: The most recent COVID-19 vaccine was administered at Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Treatment received for the adverse event include ibuprofen to try to reduce inflammation. Device Date was 18Aug2021. Clinical course: Piercing headache on Day 1, followed by 10 days of arm and hand tremors in both arms, sensation of entire torso vibrating, joint pain, muscle weakness. Day 10 (today) diagnosed as possible vaccine induced neuro inflammation  Follow-up attempts are completed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood follicle stimulating hormone normal, Blood luteinising hormone normal, Blood thyroid stimulating hormone normal, C-reactive protein normal, Condition aggravated
Clinical narrative: followed by 10 days of arm and hand tremors in both arms; muscle weakness; possible vaccine induced neuro inflammation; Piercing headache on Day 1; sensation of entire torso vibrating; joint pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 08Aug2021 11:00 (Lot number: FC3180) at the age of 41 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Allergy to pollen" (unspecified if ongoing), notes: Tree pollen; "Allergy to cat dander" (unspecified if ongoing), notes: Cat dander. Concomitant medication(s) included: VITAMINE D; MULTIVIT [VITAMINS NOS]; PROBIOTICS; TURMERIC CURCUMIN. The following information was reported: TREMOR (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "followed by 10 days of arm and hand tremors in both arms"; MUSCULAR WEAKNESS (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "muscle weakness"; INFLAMMATION (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "possible vaccine induced neuro inflammation"; HEADACHE (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "Piercing headache on Day 1"; FEELING ABNORMAL (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "sensation of entire torso vibrating"; ARTHRALGIA (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "joint pain". The events "followed by 10 days of arm and hand tremors in both arms", "muscle weakness", "possible vaccine induced neuro inflammation", "piercing headache on day 1", "sensation of entire torso vibrating" and "joint pain" were evaluated at the physician office visit and emergency room visit. Therapeutic measures were taken as a result of tremor, muscular weakness, inflammation, headache, feeling abnormal, arthralgia.  Additional information: The most recent COVID-19 vaccine was administered at Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Treatment received for the adverse event include ibuprofen to try to reduce inflammation. Device Date was 18Aug2021. Clinical course: Piercing headache on Day 1, followed by 10 days of arm and hand tremors in both arms, sensation of entire torso vibrating, joint pain, muscle weakness. Day 10 (today) diagnosed as possible vaccine induced neuro inflammation  Follow-up attempts are completed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Full blood count normal, Head discomfort, Headache, Inflammatory marker test
Clinical narrative: followed by 10 days of arm and hand tremors in both arms; muscle weakness; possible vaccine induced neuro inflammation; Piercing headache on Day 1; sensation of entire torso vibrating; joint pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 08Aug2021 11:00 (Lot number: FC3180) at the age of 41 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Allergy to pollen" (unspecified if ongoing), notes: Tree pollen; "Allergy to cat dander" (unspecified if ongoing), notes: Cat dander. Concomitant medication(s) included: VITAMINE D; MULTIVIT [VITAMINS NOS]; PROBIOTICS; TURMERIC CURCUMIN. The following information was reported: TREMOR (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "followed by 10 days of arm and hand tremors in both arms"; MUSCULAR WEAKNESS (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "muscle weakness"; INFLAMMATION (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "possible vaccine induced neuro inflammation"; HEADACHE (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "Piercing headache on Day 1"; FEELING ABNORMAL (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "sensation of entire torso vibrating"; ARTHRALGIA (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "joint pain". The events "followed by 10 days of arm and hand tremors in both arms", "muscle weakness", "possible vaccine induced neuro inflammation", "piercing headache on day 1", "sensation of entire torso vibrating" and "joint pain" were evaluated at the physician office visit and emergency room visit. Therapeutic measures were taken as a result of tremor, muscular weakness, inflammation, headache, feeling abnormal, arthralgia.  Additional information: The most recent COVID-19 vaccine was administered at Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Treatment received for the adverse event include ibuprofen to try to reduce inflammation. Device Date was 18Aug2021. Clinical course: Piercing headache on Day 1, followed by 10 days of arm and hand tremors in both arms, sensation of entire torso vibrating, joint pain, muscle weakness. Day 10 (today) diagnosed as possible vaccine induced neuro inflammation  Follow-up attempts are completed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging head normal, Metabolic function test normal, Muscle twitching, Muscular weakness, Red blood cell sedimentation rate normal
Clinical narrative: followed by 10 days of arm and hand tremors in both arms; muscle weakness; possible vaccine induced neuro inflammation; Piercing headache on Day 1; sensation of entire torso vibrating; joint pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 08Aug2021 11:00 (Lot number: FC3180) at the age of 41 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Allergy to pollen" (unspecified if ongoing), notes: Tree pollen; "Allergy to cat dander" (unspecified if ongoing), notes: Cat dander. Concomitant medication(s) included: VITAMINE D; MULTIVIT [VITAMINS NOS]; PROBIOTICS; TURMERIC CURCUMIN. The following information was reported: TREMOR (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "followed by 10 days of arm and hand tremors in both arms"; MUSCULAR WEAKNESS (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "muscle weakness"; INFLAMMATION (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "possible vaccine induced neuro inflammation"; HEADACHE (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "Piercing headache on Day 1"; FEELING ABNORMAL (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "sensation of entire torso vibrating"; ARTHRALGIA (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "joint pain". The events "followed by 10 days of arm and hand tremors in both arms", "muscle weakness", "possible vaccine induced neuro inflammation", "piercing headache on day 1", "sensation of entire torso vibrating" and "joint pain" were evaluated at the physician office visit and emergency room visit. Therapeutic measures were taken as a result of tremor, muscular weakness, inflammation, headache, feeling abnormal, arthralgia.  Additional information: The most recent COVID-19 vaccine was administered at Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Treatment received for the adverse event include ibuprofen to try to reduce inflammation. Device Date was 18Aug2021. Clinical course: Piercing headache on Day 1, followed by 10 days of arm and hand tremors in both arms, sensation of entire torso vibrating, joint pain, muscle weakness. Day 10 (today) diagnosed as possible vaccine induced neuro inflammation  Follow-up attempts are completed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rheumatoid factor negative, Sensory disturbance, Thyroxine free normal, Tremor, Vision blurred
Clinical narrative: followed by 10 days of arm and hand tremors in both arms; muscle weakness; possible vaccine induced neuro inflammation; Piercing headache on Day 1; sensation of entire torso vibrating; joint pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 08Aug2021 11:00 (Lot number: FC3180) at the age of 41 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Allergy to pollen" (unspecified if ongoing), notes: Tree pollen; "Allergy to cat dander" (unspecified if ongoing), notes: Cat dander. Concomitant medication(s) included: VITAMINE D; MULTIVIT [VITAMINS NOS]; PROBIOTICS; TURMERIC CURCUMIN. The following information was reported: TREMOR (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "followed by 10 days of arm and hand tremors in both arms"; MUSCULAR WEAKNESS (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "muscle weakness"; INFLAMMATION (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "possible vaccine induced neuro inflammation"; HEADACHE (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "Piercing headache on Day 1"; FEELING ABNORMAL (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "sensation of entire torso vibrating"; ARTHRALGIA (non-serious) with onset 08Aug2021 15:00, outcome "not recovered", described as "joint pain". The events "followed by 10 days of arm and hand tremors in both arms", "muscle weakness", "possible vaccine induced neuro inflammation", "piercing headache on day 1", "sensation of entire torso vibrating" and "joint pain" were evaluated at the physician office visit and emergency room visit. Therapeutic measures were taken as a result of tremor, muscular weakness, inflammation, headache, feeling abnormal, arthralgia.  Additional information: The most recent COVID-19 vaccine was administered at Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Treatment received for the adverse event include ibuprofen to try to reduce inflammation. Device Date was 18Aug2021. Clinical course: Piercing headache on Day 1, followed by 10 days of arm and hand tremors in both arms, sensation of entire torso vibrating, joint pain, muscle weakness. Day 10 (today) diagnosed as possible vaccine induced neuro inflammation  Follow-up attempts are completed. No further information is expected.